Newscast – Page 64 – media

Blood Type Could Affect Possibility Stroke

In a shocking discovery, a research team at Tokyo Medical and Dental University Hospital, Japan revealed that stroke patients belong to ‘O’ blood group were associated with higher death rates.
- Source: medicalxpress
- 586
- June 8, 2018
blood type Researches stroke
Discovery of Fat Burner Hormone

It was great news in the field of medicine when geneticists from University of California, Los Angeles (UCLA) created a novel technique to hunt for natural hormones that would enhance cell communication to play a major role in treating obesity, diabetes and cardiovascular diseases. Scientists discovered two hormones called "notum" and "lipocalin-5", which would aid in the fat burning process. Lipocalin-5 also enhances metabolism and absorption of dietary nutrients by reducing the risk of diabetes and obesity.
- Source: medicalxpress
- 623
- June 8, 2018
diabetes obesity Researches
Target Identification for Drug Development Against Alzheimer Disease

In a research study led by Yuksel Agca, associate professor of veterinary pathology and a researcher in the Comparative Medicine Program in the MU College of Veterinary Medicine, it was found that two proteins namely APP and PS1, were the key factors linked to Alzheimer’s disorder, by carrying out the research work in rat model. If the accumulation of amyloid-β could be manipulated, it could lead to a decrease in the onset of Alzheimer Disease.
- Source: medicalxpress
- 602
- June 8, 2018
Alzheimer's disease Researches
Artificial Intelligence to change Imaging Healthcare

Mark Michalski, MD, executive director of the Massachusetts General Hospital and Brigham and Women's Hospital Center for Clinical Data Science stated that the anticipation regarding AI is due to three key factors: the increasing contribution of digital data that can be created, the creation of algorithms that make artificial neural networks and "GPU" chip architecture (graphics processing unit), developed by NVIDIA.
- Source: HealthIT News
- 702
- June 7, 2018
AI healthcare Researches
Autism Screening App on iOS by Duke University

With parents' permission, the new app enables a smartphones' front camera to record videos of a child's reactions while watching a movie with the phone place facing them. This is done obtain autism risk behaviors such as attention, emotions and patterns. The recorded response is then sent to the research survey, where behavioral automatic coding software keeps track on the movements on the video and marks on the child's face after which their attention and emotions are measured.
- Source: Ddu
- 584
- June 7, 2018
autism mHealth Researches
FDA Recalls HeartMate device Manufactured by Abbott

This will be the second recall on a heart device this month Medtronic’s Heartware device and accessories was recalled a few days ago. This comes after Abbott issued a patch to negate cybersecurity issues 350,000 remote monitoring systems and pacemakers.
- Source: Ddu
- 735
- June 7, 2018
Abbott Company Insight heart failure medical device
Hospira Inc. Recalls Opioid Antidote Naloxone

According to the FDA, if the antidote drugs are used on a patient, they could suffer from “allergic reactions, local irritation” and a wide number of cardiovascular issues, including restriction of blood supply to tissues. The FDA stated that there has not yet been any reports of patient harm from Naloxone.
- Source: Ddu
- 634
- June 7, 2018
Company Insights FDA opioid
Apple to launch new Health Record API for developers

This week Apple announced that researchers and app developers can now have access to a Health Record API (Application Programming Interface) to develop applications, with the permission to use the patient’s data to provide them with easy access to health records.
- Source: drugdu
- 728
- June 7, 2018
Company Insight digital health mHealth
Smartphone Video Based App for TB

A research team from John Hopkins University School of Medicine created a cost-effective and patient-centric smartphone video-based app, which would substitute the daily in-person visits by a healthcare worker required for TB therapy, known as DOT (Directly Observed Therapy).
- Source: Ddu
- 813
- June 7, 2018
mHealth Researches tuberculosis
Blood Test to Predict Drug Activity Against Breast Cancer

At present, breast cancer patients need to wait for nearly two to three months to find out via a scan whether palbociclib is working. This new test could detect the circulating tumor DNA which enters the bloodstream. By measuring and comparing PIK3CA levels in a blood test before and 15 post palbociclib therapy, one could predict the effectiveness of the drug.
- Source: Ddu
- 970
- June 7, 2018
blood test breast cancer Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.